Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
331,147,981
-
Share change
-
+3,653,932
-
Total reported value
-
$14,434,394,046
-
Put/Call ratio
-
63%
-
Price per share
-
$43.56
-
Number of holders
-
913
-
Value change
-
+$157,492,937
-
Number of buys
-
431
-
Number of sells
-
348
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2022
As of 31 Mar 2022,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
913 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
331,147,981 shares.
The largest 10 holders included
Dodge & Cox, Capital International Investors, Fisher Asset Management, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Black Creek Investment Management Inc., JTC Employer Solutions Trustee Ltd, and STATE STREET CORP.
This page lists
913
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.